Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells
- PMID: 20574005
- DOI: 10.4049/jimmunol.1000560
Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells
Abstract
TNF is a pleiotropic cytokine with differential effects on immune cells and diseases. Anti-TNF therapy was shown to be effective in rheumatoid arthritis but proved inefficient or even detrimental in other autoimmune diseases. We studied the role of TNF in the induction of Ag-specific regulatory T cells (Tregs) by tolerogenic vitamin D3-modulated human dendritic cells (VD3-DCs), which previously were shown to release high amounts of soluble TNF (sTNF) upon maturation with LPS. First, production of TNF by modulated VD3-DCs was analyzed upon maturation with LPS or CD40L with respect to both secreted (cleaved) TNF (sTNF) and expression of the membrane-bound (uncleaved) form of TNF (mTNF). Next, TNF antagonists were tested for their effect on induction of Ag-specific Tregs by modulated DCs and the subsequent functionality of these Tregs. VD3-DCs expressed greater amounts of mTNF than did control DCs (nontreated DCs), independent of the maturation protocol. Inhibition of TNF with anti-TNF Ab (blocking both sTNF and mTNF) during the priming of Tregs with VD3-DCs prevented generation of Tregs and their suppression of proliferation of CD4(+) T cells. In contrast, sTNF receptor II (sTNFRII), mainly blocking sTNF, did not change the suppressive capacity of Tregs. Blocking of TNFRII by anti-CD120b Ab during Treg induction similarly abrogated their subsequent suppressive function. These data point to a specific role for mTNF on VD3-DCs in the induction of Ag-specific Tregs. Interaction between mTNF and TNFRII instructs the induction of suppressive Tregs by VD3-DCs. Anti-TNF therapy may therefore act adversely in different patients or disease pathways.
Similar articles
-
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1.Eur J Immunol. 2009 Nov;39(11):3147-59. doi: 10.1002/eji.200839103. Eur J Immunol. 2009. PMID: 19688742
-
Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.J Immunol. 2010 Feb 15;184(4):1765-75. doi: 10.4049/jimmunol.0902133. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083662
-
Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory T cells.J Immunol. 2011 Dec 15;187(12):6357-64. doi: 10.4049/jimmunol.1101638. Epub 2011 Nov 14. J Immunol. 2011. PMID: 22084438
-
The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.Semin Immunol. 2006 Apr;18(2):93-102. doi: 10.1016/j.smim.2006.01.009. Epub 2006 Feb 15. Semin Immunol. 2006. PMID: 16469503 Review.
-
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.
Cited by
-
Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells.Sci Adv. 2020 Sep 30;6(40):eaba6584. doi: 10.1126/sciadv.aba6584. Print 2020 Sep. Sci Adv. 2020. PMID: 32998896 Free PMC article.
-
Treg cells in rheumatoid arthritis: an update.Curr Rheumatol Rep. 2013 Sep;15(9):352. doi: 10.1007/s11926-013-0352-0. Curr Rheumatol Rep. 2013. PMID: 23888361 Review.
-
Harnessing Newton's third-law paradigm to treat autoimmune diseases and chronic inflammations.Inflamm Res. 2020 Sep;69(9):813-824. doi: 10.1007/s00011-020-01374-6. Epub 2020 Jun 26. Inflamm Res. 2020. PMID: 32591922 Review.
-
TNF Blockade Maintains an IL-10+ Phenotype in Human Effector CD4+ and CD8+ T Cells.Front Immunol. 2017 Feb 15;8:157. doi: 10.3389/fimmu.2017.00157. eCollection 2017. Front Immunol. 2017. PMID: 28261215 Free PMC article.
-
Myeloid and T Cell-Derived TNF Protects against Central Nervous System Tuberculosis.Front Immunol. 2017 Feb 23;8:180. doi: 10.3389/fimmu.2017.00180. eCollection 2017. Front Immunol. 2017. PMID: 28280495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials